PT-141 (Bremelanotide) (10mg)
Research
Category: Research
Historical Development
PT-141, also known as Bremelanotide, is an investigational synthetic peptide derived from Melanotan-based research. Originally developed during studies involving melanocortin receptor signaling, scientific interest shifted toward its potential influence on neuroendocrine pathways, behavioral responses, and central nervous system signaling. Research throughout the 2000s and beyond has explored its interaction with melanocortin receptors involved in motivation, reward processing, and physiological response pathways.
Receptor Mechanisms and Intracellular Signaling
PT-141 has been investigated for its interaction with melanocortin receptor systems, particularly within the central nervous system.
Experimental studies suggest potential influence on:
- Melanocortin receptor signaling pathways
- Neuroendocrine regulatory mechanisms
- Dopaminergic-related signaling
- Central nervous system response pathways
- Behavioral and motivational signaling networks
- Hypothalamic activity regulation
- Neurotransmitter-related cellular pathways
- Physiological response signaling mechanisms
Preclinical investigations have also explored its relationship with melanocortin receptor subtypes involved in neurological and endocrine communication pathways.
Scientific Research and Studies
In vitro, preclinical, and investigational clinical studies have evaluated the effects of PT-141 on melanocortin receptor activity and neuroendocrine signaling pathways.
Research investigations have reported:
- Activation of melanocortin-related signaling mechanisms
- Modulation of central nervous system pathways
- Changes in neuroendocrine-related biomarkers
- Effects on behavioral and motivational signaling
- Alterations in hypothalamic regulatory activity
- Influence on neurotransmitter-associated pathways
- Experimental physiological response modulation
Current research continues to evaluate long-term safety, receptor selectivity, and neuroendocrine outcomes across various investigational settings.
References
Selected literature involving PT-141 (Bremelanotide), melanocortin receptor signaling, neuroendocrine regulation, central nervous system pathways, neurotransmitter-related mechanisms, hypothalamic activity, and investigational peptide research studies.